Track BlossomHill Therapeutics's total assets ($120M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
BlossomHill Therapeutics (BLSM) currently reports a total assets of $120M as of June 2026. Use the charts on this page to explore BlossomHill Therapeutics's total assets history and peer comparisons.
BlossomHill Therapeutics reported $120M in total assets as of June 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total assets of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BlossomHill Therapeutics, and consider following BLSM for alerts when major investors trade the stock.
BlossomHill Therapeutics is classified in the Healthcare sector. On total assets, it currently shows $120M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BLSM with unrelated industries.